Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Surveillance Outcomes and Intensity of Salvage Therapy Among Human Papillomavirus-Associated Oropharyngeal Cancers.

Arvold ND, McBride SM.

JAMA Otolaryngol Head Neck Surg. 2020 Jan 16. doi: 10.1001/jamaoto.2019.4198. [Epub ahead of print] No abstract available.

PMID:
31944224
2.

The Impact of pH on Clostridioides difficile Sporulation and Physiology.

Wetzel D, McBride SM.

Appl Environ Microbiol. 2020 Feb 3;86(4). pii: e02706-19. doi: 10.1128/AEM.02706-19. Print 2020 Feb 3.

PMID:
31811041
3.

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.

Dunn LA, Riaz N, Fury MG, McBride SM, Michel L, Lee NY, Sherman EJ, Baxi SS, Haque SS, Katabi N, Wong RJ, Xiao H, Ho AL, Pfister DG.

Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):564-570. doi: 10.1016/j.ijrobp.2019.09.050. Epub 2019 Oct 31.

PMID:
31678634
4.

Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation.

Edwards AN, Krall EG, McBride SM.

J Bacteriol. 2020 Jan 2;202(2). pii: e00586-19. doi: 10.1128/JB.00586-19. Print 2020 Jan 2.

PMID:
31659010
5.

Phase variation of a signal transduction system controls Clostridioides difficile colony morphology, motility, and virulence.

Garrett EM, Sekulovic O, Wetzel D, Jones JB, Edwards AN, Vargas-Cuebas G, McBride SM, Tamayo R.

PLoS Biol. 2019 Oct 28;17(10):e3000379. doi: 10.1371/journal.pbio.3000379. eCollection 2019 Oct.

6.

Regulation and Anaerobic Function of the Clostridioides difficile β-Lactamase.

Sandhu BK, Edwards AN, Anderson SE, Woods EC, McBride SM.

Antimicrob Agents Chemother. 2019 Dec 20;64(1). pii: e01496-19. doi: 10.1128/AAC.01496-19. Print 2019 Dec 20.

PMID:
31611350
7.

Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.

Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Lobaugh SM, Grecula JC, Mitchell DL, Wobb JL, Miller ED, Blakaj DM, Diavolitsis VM, Lee N, Bhatt AD.

Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32736. [Epub ahead of print]

PMID:
31609479
8.

Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy.

Damerla RR, Lee NY, You D, Soni R, Shah R, Reyngold M, Katabi N, Wu V, McBride SM, Tsai CJ, Riaz N, Powell SN, Babady NE, Viale A, Higginson DS.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00276. Epub 2019 Apr 3.

9.

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data.

Weg ES, Pei X, Kollmeier MA, McBride SM, Zelefsky MJ.

Adv Radiat Oncol. 2019 Apr 4;4(3):492-499. doi: 10.1016/j.adro.2019.03.012. eCollection 2019 Jul-Sep.

10.

RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.

Edwards AN, Anjuwon-Foster BR, McBride SM.

mBio. 2019 Mar 12;10(2). pii: e01991-18. doi: 10.1128/mBio.01991-18.

11.

Editorial.

Fagan R, McBride SM, Shen A.

Anaerobe. 2018 Oct;53:1. doi: 10.1016/j.anaerobe.2018.09.009. No abstract available.

PMID:
30724171
12.
13.

.Clostridioides difficile.

Sandhu BK, McBride SM.

Trends Microbiol. 2018 Dec;26(12):1049-1050. doi: 10.1016/j.tim.2018.09.004. Epub 2018 Oct 5.

14.

Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.

Ma J, Lok BH, Zong J, Gutiontov SI, Cai X, Bell AC, Shcherba M, Xiao H, Sherman EJ, Tsai CJ, Riaz N, McBride SM, Cahlon O, Lee NY.

Int J Part Ther. 2018 Spring;4(4):10-19. doi: 10.14338/IJPT-18-00003.1.

15.

The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37.

Woods EC, Edwards AN, Childress KO, Jones JB, McBride SM.

PLoS Pathog. 2018 Aug 20;14(8):e1007153. doi: 10.1371/journal.ppat.1007153. eCollection 2018 Aug.

16.

Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240.

Woods EC, Wetzel D, Mukerjee M, McBride SM.

Anaerobe. 2018 Oct;53:108-115. doi: 10.1016/j.anaerobe.2018.06.013. Epub 2018 Jun 22.

17.

Occult Suicidality and Psychiatric Disease Among Emergency Department Patients with Low-acuity Chief Complaints.

McBride SM, Braz VA, Jones CW.

West J Emerg Med. 2018 May;19(3):573-578. doi: 10.5811/westjem.2018.2.36399. Epub 2018 Mar 13.

18.

Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.

Katsoulakis E, Leeman JE, Lok BH, Shi W, Zhang Z, Tsai JC, McBride SM, Sherman EJ, Cohen M, Wong R, Ganly I, Lee NY, Riaz N.

Laryngoscope. 2018 Nov;128(11):2539-2545. doi: 10.1002/lary.27191. Epub 2018 Apr 10.

19.

Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks.

Leeman JE, McBride SM, Spielsinger D, Sherman EJ, Wong R, Riaz N, Lee NY, Tsai CJ.

Int J Cancer. 2018 Jun 15;142(12):2485-2490. doi: 10.1002/ijc.31277. Epub 2018 Feb 10.

20.

Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis.

Nawrocki KL, Wetzel D, Jones JB, Woods EC, McBride SM.

Environ Microbiol. 2018 Apr;20(4):1419-1435. doi: 10.1111/1462-2920.14048. Epub 2018 Feb 9.

21.

Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.

Romesser PB, Pei X, Shi W, Zhang Z, Kollmeier M, McBride SM, Zelefsky MJ.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):59-67. doi: 10.1016/j.ijrobp.2017.09.003. Epub 2017 Oct 13.

PMID:
29254782
22.

Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma.

Cracchiolo JR, Patel K, Migliacci JC, Morris LT, Ganly I, Roman BR, McBride SM, Tabar VS, Cohen MA.

J Surg Oncol. 2018 Mar;117(4):756-764. doi: 10.1002/jso.24923. Epub 2017 Nov 28.

23.

Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Teo MY, O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Nat Rev Clin Oncol. 2018 Mar;15(3):150. doi: 10.1038/nrclinonc.2017.177. Epub 2017 Nov 8.

PMID:
29115302
24.

Density, abundance, survival, and ranging patterns of common bottlenose dolphins (Tursiops truncatus) in Mississippi Sound following the Deepwater Horizon oil spill.

Mullin KD, McDonald T, Wells RS, Balmer BC, Speakman T, Sinclair C, Zolman ES, Hornsby F, McBride SM, Wilkinson KA, Schwacke LH.

PLoS One. 2017 Oct 20;12(10):e0186265. doi: 10.1371/journal.pone.0186265. eCollection 2017.

25.

Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma.

Sayed Z, Migliacci JC, Cracchiolo JR, Barker CA, Lee NY, McBride SM, Tabar VS, Ganly I, Patel SG, Morris LT, Roman BR, Shoushtari AN, Cohen MA.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1220-1227. doi: 10.1001/jamaoto.2017.2011. No abstract available.

26.

Drug development for noncastrate prostate cancer in a changed therapeutic landscape.

Teo MY, O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Nat Rev Clin Oncol. 2018 Mar;15(3):168-182. doi: 10.1038/nrclinonc.2017.160. Epub 2017 Oct 17. Review. Erratum in: Nat Rev Clin Oncol. 2017 Nov 08;:.

27.

A Nutrient-Regulated Cyclic Diguanylate Phosphodiesterase Controls Clostridium difficile Biofilm and Toxin Production during Stationary Phase.

Purcell EB, McKee RW, Courson DS, Garrett EM, McBride SM, Cheney RE, Tamayo R.

Infect Immun. 2017 Aug 18;85(9). pii: e00347-17. doi: 10.1128/IAI.00347-17. Print 2017 Sep.

28.

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.

Leeman JE, Li JG, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, Lupovitch E, McBride SM, Tsai CJ, Boyle JO, Roman BR, Morris LGT, Dunn LA, Sherman EJ, Lee NY, Riaz N.

JAMA Oncol. 2017 Nov 1;3(11):1487-1494. doi: 10.1001/jamaoncol.2017.0973.

29.

Determination of the in vitro Sporulation Frequency of Clostridium difficile.

Edwards AN, McBride SM.

Bio Protoc. 2017 Feb 5;7(3). pii: e2125. doi: 10.21769/BioProtoc.2125.

30.

Genome Sequence of a Toxin-Positive Clostridium difficile Strain Isolated from Murine Feces.

Etienne-Mesmin L, Chassaing B, Adekunle O, Mattei LM, Edwards AN, McBride SM, Bushman FD, Gewirtz AT.

Genome Announc. 2017 Apr 6;5(14). pii: e00088-17. doi: 10.1128/genomeA.00088-17.

31.

Author Reply.

O'Shaughnessy MJ, McBride SM, Vargas HA, Scher HI.

Urology. 2017 Apr;102:172. doi: 10.1016/j.urology.2016.10.046. Epub 2017 Mar 6. No abstract available.

PMID:
28279479
32.

Regulation of antimicrobial resistance by extracytoplasmic function (ECF) sigma factors.

Woods EC, McBride SM.

Microbes Infect. 2017 Apr - May;19(4-5):238-248. doi: 10.1016/j.micinf.2017.01.007. Epub 2017 Jan 30. Review.

33.

Proton Radiation Therapy for Local Control in a Case of Osteosarcoma of the Neck.

Gutiontov SI, Zumsteg ZS, Lok BH, Berry S, Tsai CJ, McBride SM, Riaz N, Cahlon O, Lee NY.

Int J Part Ther. 2017 Winter;3(3):421-428. doi: 10.14338/IJPT-16-00015.1. Epub 2017 Mar 14.

34.

The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zumsteg ZS, Lok BH, Ho AS, Drill E, Zhang Z, Riaz N, Shiao SL, Ma J, McBride SM, Tsai CJ, Baxi SS, Sherman EJ, Lee NY.

Cancer. 2017 Apr 15;123(8):1345-1353. doi: 10.1002/cncr.30495. Epub 2016 Dec 16.

35.

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

O'Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES, Bellomo LP, Sjoberg DD, Heller G, Zelefsky MJ, Eastham JA, Scardino PT, Scher HI.

Urology. 2017 Apr;102:164-172. doi: 10.1016/j.urology.2016.10.044. Epub 2016 Nov 22.

36.

Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?

Jones CW, Braz VA, McBride SM, Roberts BW, Platts-Mills TF.

BMJ Open. 2016 Nov 24;6(11):e013649. doi: 10.1136/bmjopen-2016-013649.

37.

Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells.

Edwards AN, Karim ST, Pascual RA, Jowhar LM, Anderson SE, McBride SM.

Front Microbiol. 2016 Oct 26;7:1698. eCollection 2016.

38.

What's a SNP between friends: The influence of single nucleotide polymorphisms on virulence and phenotypes of Clostridium difficile strain 630 and derivatives.

Collery MM, Kuehne SA, McBride SM, Kelly ML, Monot M, Cockayne A, Dupuy B, Minton NP.

Virulence. 2017 Aug 18;8(6):767-781. doi: 10.1080/21505594.2016.1237333. Epub 2016 Sep 21.

39.

The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile.

Childress KO, Edwards AN, Nawrocki KL, Anderson SE, Woods EC, McBride SM.

Infect Immun. 2016 Nov 18;84(12):3434-3444. Print 2016 Dec.

40.

Isolating and Purifying Clostridium difficile Spores.

Edwards AN, McBride SM.

Methods Mol Biol. 2016;1476:117-28. doi: 10.1007/978-1-4939-6361-4_9.

41.

Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models.

Choi CH, Schoenfeld BP, Bell AJ, Hinchey J, Rosenfelt C, Gertner MJ, Campbell SR, Emerson D, Hinchey P, Kollaros M, Ferrick NJ, Chambers DB, Langer S, Sust S, Malik A, Terlizzi AM, Liebelt DA, Ferreiro D, Sharma A, Koenigsberg E, Choi RJ, Louneva N, Arnold SE, Featherstone RE, Siegel SJ, Zukin RS, McDonald TV, Bolduc FV, Jongens TA, McBride SM.

Front Behav Neurosci. 2016 Jun 30;10:136. doi: 10.3389/fnbeh.2016.00136. eCollection 2016.

42.

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Morris LGT, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL.

JAMA Oncol. 2017 Feb 1;3(2):244-255. doi: 10.1001/jamaoncol.2016.1790.

43.

CodY-Dependent Regulation of Sporulation in Clostridium difficile.

Nawrocki KL, Edwards AN, Daou N, Bouillaut L, McBride SM.

J Bacteriol. 2016 Jul 13;198(15):2113-30. doi: 10.1128/JB.00220-16. Print 2016 Aug 1.

44.

Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model.

Monyak RE, Emerson D, Schoenfeld BP, Zheng X, Chambers DB, Rosenfelt C, Langer S, Hinchey P, Choi CH, McDonald TV, Bolduc FV, Sehgal A, McBride SMJ, Jongens TA.

Mol Psychiatry. 2017 Aug;22(8):1140-1148. doi: 10.1038/mp.2016.51. Epub 2016 Apr 19.

45.

The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor σV in Response to Lysozyme.

Woods EC, Nawrocki KL, Suárez JM, McBride SM.

Infect Immun. 2016 May 24;84(6):1902-1916. doi: 10.1128/IAI.00207-16. Print 2016 Jun.

46.

A novel regulator controls Clostridium difficile sporulation, motility and toxin production.

Edwards AN, Tamayo R, McBride SM.

Mol Microbiol. 2016 Jun;100(6):954-71. doi: 10.1111/mmi.13361. Epub 2016 Mar 22.

47.

Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.

Ghose C, Eugenis I, Sun X, Edwards AN, McBride SM, Pride DT, Kelly CP, Ho DD.

Emerg Microbes Infect. 2016 Feb 3;5:e8. doi: 10.1038/emi.2016.8.

48.

Immunogenicity and protective efficacy of Clostridium difficile spore proteins.

Ghose C, Eugenis I, Edwards AN, Sun X, McBride SM, Ho DD.

Anaerobe. 2016 Feb;37:85-95. doi: 10.1016/j.anaerobe.2015.12.001. Epub 2015 Dec 11.

49.

Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.

Setton J, Han J, Kannarunimit D, Wuu YR, Rosenberg SA, DeSelm C, Wolden SL, Jillian Tsai C, McBride SM, Riaz N, Lee NY.

Oral Oncol. 2016 Feb;53:67-73. doi: 10.1016/j.oraloncology.2015.11.015. Epub 2015 Dec 7.

50.

Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.

Lok BH, Jiang G, Gutiontov S, Lanning RM, Sridhara S, Sherman EJ, Tsai CJ, McBride SM, Riaz N, Lee NY.

Oral Oncol. 2015 Oct;51(10):957-62. doi: 10.1016/j.oraloncology.2015.07.011. Epub 2015 Aug 14.

Supplemental Content

Loading ...
Support Center